3.43
Oramed Pharmaceuticals Inc (ORMP) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
-
|
- | 2.00 | - | - |
| Cost Of Revenue |
-
|
- | 1.987 | - | - |
| Gross Profit |
-
|
- | 0.013 | - | - |
|
|
2.49%
2.427
|
2.489 | 4.513 | - | - |
| Benefits Costs and Expenses |
352.65%
-59.45
|
-13.13 | 9.058 | - | - |
| Costs And Expenses |
352.65%
-59.45
|
-13.13 | 9.058 | - | - |
| Operating Income/Loss |
2.49%
-2.427
|
-2.489 | -4.50 | -3.595 | -3.089 |
| Nonoperating Income/Loss |
300.04%
61.47
|
15.37 | -2.558 | -6.188 | -15.42 |
| Income/Loss From Continuing Operations Before Tax |
352.65%
59.45
|
13.13 | -7.058 | -9.783 | -18.51 |
| Income Tax Expense/Benefit |
8,879%
11.06
|
-0.126 | 0.584 | 0.416 | 1.133 |
| Income/Loss From Continuing Operations After Tax |
264.92%
48.39
|
13.26 | -7.642 | -10.20 | -19.64 |
|
|
264.92%
48.39
|
13.26 | -7.642 | -10.16 | -19.64 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
78.57%
-0.006
|
-0.028 | - | 0.076 | -0.023 |
| Basic Average Shares |
0.03%
41.76
|
41.74 | 41.23 | -0.0537 | 40.90 |
| Diluted Average Shares |
0.39%
42.77
|
42.61 | 41.23 | -0.0537 | 40.90 |
| Basic Earnings Per Share |
262.50%
1.16
|
0.32 | -0.19 | -0.26 | -0.48 |
| Diluted Earnings Per Share |
264.52%
1.13
|
0.31 | -0.19 | -0.26 | -0.48 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):